Tretinoin
CAS No. 302-79-4
Tretinoin( atRA | NSC 122578 | NSC 122758 | RA | Vitamin A Acid )
Catalog No. M13949 CAS No. 302-79-4
An important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 30 | In Stock |
|
| 100MG | 43 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTretinoin
-
NoteResearch use only, not for human use.
-
Brief DescriptionAn important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS.
-
DescriptionAn important regulator of gene expression during growth and development, and in neoplasm. Tretinoin, also known as retinoic acid and derived from maternal vitamin a, is essential for normal growth; and embryonic development. An excess of tretinoin can be teratogenic. It is used in the treatment of psoriasis; acne vulgaris; and several other skin disease. It has also been approved for use in promyelocytic leukemia (LEUKEMIA, PROMYELOCYTIC, ACUTE).
-
In VitroRetinoic acid (GMP) time- and dose- dependently induces differentiation of EC cells and ES cells into specific cell types.Retinoic acid (GMP) induces partial differentiation of F9 embryonal carcinoma cells into endoderm cells.Retinoic acid (GMP) (100 nM; 2-8 d) promotes photoreceptor differentiation in early postnatal retinal cultures.Retinoic acid (GMP) (0.1 μM; 10-12 d) induces human SH-SY5Y neuroblastoma cells differentiation with long cell processes. Retinoic acid (GMP) (0-10 μM; 48 h) dose-dependently induces morphologic differentiation of LA-N-1 human neuroblastoma cells.
-
In VivoRetinoic acid (GMP) (0.3 μM; embryos are immersed in tank water containing retinoic acid) accelerates of rod differentiation is observed following 24 and 48 hours of applicationin zebrafish.
-
SynonymsatRA | NSC 122578 | NSC 122758 | RA | Vitamin A Acid
-
PathwayMetabolic Enzyme/Protease
-
TargetRetinoid Receptor
-
RecptorRAR
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number302-79-4
-
Formula Weight300.44
-
Molecular FormulaC20H28O2
-
Purity>98% (HPLC)
-
SolubilityEthanol: 6 mg/mL (19.97 mM); DMSO: 60 mg/mL (199.73 mM)
-
SMILESO=C(O)/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C
-
Chemical Name(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Manzano VM, et al. J Pharmacol Exp Ther, 1999, 289(1), 123-132.
molnova catalog
related products
-
K-8012
K-8012 is a modulator of the N-terminally truncated RXRα and improves anticancer activities in an RXRα-dependent manner.
-
AGN 193109
AGN 193109, a retinoid analog, is a potent and specific antagonist of RARs (Kds: 2 nM, 2 nM, and 3 nM for RARα, RARβ, and RARγ).AGN 193109 is completely RAR specific because it does not bind to or transactivate through any of the RXRs.
-
Mofarotene
Mofarotene (Ro-40-8757) is a small molecule compound that shows considerable antitumor activity in many cancer cell lines and can be used for the treatment of tumors and respiratory diseases.
Cart
sales@molnova.com